Identifier Randomization: An Efficient Protection Against CAN-Bus Attacks

2018 ◽  
pp. 219-254 ◽  
Author(s):  
Khaled Karray ◽  
Jean-Luc Danger ◽  
Sylvain Guilley ◽  
M. Abdelaziz Elaabid
Keyword(s):  
Can Bus ◽  
Efficient Protection

Efficient protection of potato from diseases of various etiology under conditions of the Mosraw region

2019 ◽  
Vol 326 (3) ◽  
pp. 49-53
Author(s):  
M.A. Kuznetsova ◽  
◽  
A.N. Rogozhin ◽  
V.N. Demidova ◽  
T.I. Smetanina ◽  
...  
Keyword(s):  
Efficient Protection

Application of CAN bus hybrid scheduling algorithm in HEV control system

2012 ◽  
Vol 26 (1) ◽  
pp. 31-36
Author(s):  
Andong Yin ◽  
Yunxiao Zhu ◽  
Hao Jiang ◽  
Han Zhao
Keyword(s):  
Control System ◽  
Can Bus ◽  
Scheduling Algorithm ◽  
Hybrid Scheduling

scholarly journals Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses

Vaccines ◽  
2021 ◽  
Vol 9 (4) ◽  
pp. 353
Author(s):  
Yo Han Jang ◽  
Baik L. Seong
Keyword(s):  
Immune Responses ◽  
Neutralizing Antibodies ◽  
Influenza Virus Infection ◽  
Influenza Viruses ◽  
Influenza Vaccines ◽  
Immune Correlates ◽  
Protection Efficacy ◽  
Public Health Challenge ◽  
Efficient Protection ◽  
Universal Influenza Vaccine

Influenza virus infection remains a major public health challenge, causing significant morbidity and mortality by annual epidemics and intermittent pandemics. Although current seasonal influenza vaccines provide efficient protection, antigenic changes of the viruses often significantly compromise the protection efficacy of vaccines, rendering most populations vulnerable to the viral infection. Considerable efforts have been made to develop a universal influenza vaccine (UIV) able to confer long-lasting and broad protection. Recent studies have characterized multiple immune correlates required for providing broad protection against influenza viruses, including neutralizing antibodies, non-neutralizing antibodies, antibody effector functions, T cell responses, and mucosal immunity. To induce broadly protective immune responses by vaccination, various strategies using live attenuated influenza vaccines (LAIVs) and novel vaccine platforms are under investigation. Despite superior cross-protection ability, very little attention has been paid to LAIVs for the development of UIV. This review focuses on immune responses induced by LAIVs, with special emphasis placed on the breadth and the potency of individual immune correlates. The promising prospect of LAIVs to serve as an attractive and reliable vaccine platforms for a UIV is also discussed. Several important issues that should be addressed with respect to the use of LAIVs as UIV are also reviewed.

Sign in / Sign up

Export Citation Format

Share Document